Literature DB >> 11168978

Reactive carbonyl compounds related uremic toxicity ("carbonyl stress").

T Miyata1, S Sugiyama, A Saito, K Kurokawa.   

Abstract

Many studies on uremic toxins have focused on enzymatic biochemistry. Recently, attention has turned to nonenzymatic biochemistry, especially progressive and irreversible modifications of proteins. Two different approaches opened the field of irreversible nonenzymatic modifications of proteins in uremia: the advanced glycation end products (AGEs) derived from the Maillard reaction and the advanced lipoxidation end products (ALEs) derived from lipid peroxidation. They have revealed the accumulation of reactive carbonyl compounds (RCOs) derived from carbohydrates and lipids and the subsequent carbonyl modifications of proteins ("carbonyl stress"). In this article, we describe the causal role of various RCOs and AGEs/ALEs accumulating in uremia, the clinical consequences of carbonyl stress in uremia, and finally, the therapeutic perspectives. We propose carbonyl stress as a new uremic toxicity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11168978     DOI: 10.1046/j.1523-1755.2001.59780025.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  14 in total

Review 1.  Review article: Biomarkers of clinical outcomes in advanced chronic kidney disease.

Authors:  Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nephrology (Carlton)       Date:  2009-06       Impact factor: 2.506

2.  The oxidative effect of prolonged CO2 pneumoperitoneum on renal tissue of rats.

Authors:  G Akbulut; C Polat; F Aktepe; S Yilmaz; A Kahraman; M Serteser; C Gökçe; O Gökçe
Journal:  Surg Endosc       Date:  2004-06-29       Impact factor: 4.584

3.  Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease.

Authors:  Esther M M Ooi; Doris T Chan; Gerald F Watts; Dick C Chan; Theodore W K Ng; Gursharan K Dogra; Ashley B Irish; P Hugh R Barrett
Journal:  J Lipid Res       Date:  2011-02-06       Impact factor: 5.922

4.  Multivariate analysis of matrix-assisted laser desorption/ionization mass spectrometric data related to glycoxidation products of human globins in nephropathic patients.

Authors:  Annunziata Lapolla; Eugenio Ragazzi; Barbara Andretta; Domenico Fedele; Michela Tubaro; Roberta Seraglia; Laura Molin; Pietro Traldi
Journal:  J Am Soc Mass Spectrom       Date:  2007-02-22       Impact factor: 3.109

Review 5.  Advanced glycation end products: role in pathology of diabetic cardiomyopathy.

Authors:  Vijaya Lakshmi Bodiga; Sasidhar Reddy Eda; Sreedhar Bodiga
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

6.  Study of an unusual advanced glycation end-product (AGE) derived from glyoxal using mass spectrometry.

Authors:  Andrea F Lopez-Clavijo; Carlos A Duque-Daza; Isolda Romero Canelon; Mark P Barrow; David Kilgour; Naila Rabbani; Paul J Thornalley; Peter B O'Connor
Journal:  J Am Soc Mass Spectrom       Date:  2014-01-28       Impact factor: 3.109

7.  Impact of dialysis modality on the survival of patients with end-stage renal disease and prior stroke.

Authors:  I-Kuan Wang; Wen-Miin Liang; Cheng-Li Lin; Yao-Lung Liu; Chiz-Tzung Chang; Tzung-Hai Yen; Chiu-Ching Huang; Fung-Chang Sung
Journal:  Int Urol Nephrol       Date:  2015-11-11       Impact factor: 2.370

8.  Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III.

Authors:  Doris T Chan; Gursharan K Dogra; Ashley B Irish; Esther M Ooi; P Hugh Barrett; Dick C Chan; Gerald F Watts
Journal:  J Lipid Res       Date:  2009-06-21       Impact factor: 5.922

9.  Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products.

Authors:  K N Lai; J C K Leung; L Y Y Chan; F F K Li; S C W Tang; M F Lam; K C Tse; T P Yip; T M Chan; A Wieslander; H Vlassara
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

10.  How the duration period of erythropoietin treatment influences the oxidative status of hemodialysis patients.

Authors:  Zorica M Dimitrijevic; Tatjana P Cvetkovic; Vidojko M Djordjevic; Dusica D Pavlovic; Nikola Z Stefanovic; Ivana R Stojanovic; Goran J Paunovic; Radmila M Velickovic-Radovanovic
Journal:  Int J Med Sci       Date:  2012-10-26       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.